Skip to the page

Data / Form D filings / Sedare Biosciences, Inc.

Sedare Biosciences, Inc.: Form D filing

Sedare Biosciences, Inc., a technology company in Palo Alto, CA, filed a Form D with the SEC in 2024. The latest, on January 23, 2024, reports $2.5 million sold of a $4.1 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
628 MIDDLEFIELD ROAD, Palo Alto, CA, 94301
Phone
(612) 710-1954
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2008582

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 23, 2024New notice$4,100,000$2,500,000$1,600,0001Jan 10, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Christian RichardDirector
Donald McCarthyExecutive Officer, Director
Ravichandran RaoExecutive Officer
David ParryExecutive Officer, Director

Other technology companies in California that filed recently

Every Form D from the week of Jan 22, 2024 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Sedare Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.